TGTX
TG Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -9.1% ·
aandelenstroom -1.4% ·
netto nieuwe posities -10.0%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 117 | +11 | 84.53M | $4.64B | +13 | −2 |
| Q1 2026 | 109 | 0 | 78.24M | $2.60B | +7 | −7 |
| Q4 2025 | 108 | 0 | 85.68M | $2.55B | — | — |
| Q3 2025 | 18 | +1 | 56.55M | $2.04B | +1 | −1 |
| Q2 2025 | 15 | 0 | 56.34M | $2.03B | +1 | −1 |
| Q1 2025 | 12 | +2 | 14.38M | $567.04M | +2 | — |
| Q4 2024 | 10 | -1 | 14.56M | $438.37M | — | −1 |
| Q3 2024 | 10 | -3 | 5.57M | $130.22M | — | −3 |
| Q2 2024 | 13 | — | 11.93M | $212.32M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 9.20M | — | $276.92M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 3.19M | -0.4% | $96.15M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passief) | 3.19M | -0.4% | $96.15M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Two Sigma Investments ✦ | 606.21K | -43.0% | $18.25M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 513.96K | +310.7% | $15.47M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Norges Bank ✦ (passief) | 401.50K | -8.2% | $12.09M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 297.10K | +264.5% | $8.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 297.10K | +264.5% | $8.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 168.50K | -57.3% | $5.07M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 168.50K | -57.3% | $5.07M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 67.87K | +14.2% | $2.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 67.87K | +14.2% | $2.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 67.87K | +14.2% | $2.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 63.51K | -13.4% | $1.91M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Wellington Management ✦ | 63.51K | -13.4% | $1.91M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Wellington Management ✦ | 63.51K | -13.4% | $1.91M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Wellington Management ✦ | 63.51K | -13.4% | $1.91M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 50.95K | -55.8% | $1.53M | 0.0% | ▼ Trim | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Millennium Management | $275,862 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 359 houders, 105.22M aandelen, $3.44B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.